Royal Bank Of Canada Vir Biotechnology, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 12,451 shares of VIR stock, worth $92,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,451

Previous 10,415 19.55%

Holding current value

$92,137

Previous $92,000 1.09%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$7.26 - $10.7 $14,781 - $21,785	2,036 Added 19.55%	12,451 $93,000
Q2 2024 Aug 14, 2024	BUY	$7.63 - $12.66 $37,737 - $62,616	4,946 Added 90.44%	10,415 $92,000
Q1 2024 Nov 05, 2024	SELL	$8.6 - $11.9 $42,535 - $58,857	-4,946 Reduced 47.49%	5,469 $55,000
Q1 2024 May 15, 2024	SELL	$8.6 - $11.9 $194,618 - $269,297	-22,630 Reduced 80.54%	5,469 $55,000
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $76,373 - $101,274	9,842 Added 53.91%	28,099 $282,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $50,992 - $137,354	5,579 Added 44.01%	18,257 $171,000
Q2 2023 Aug 14, 2023	BUY	$23.2 - $27.29 $86,141 - $101,327	3,713 Added 41.42%	12,678 $310,000
Q1 2023 May 15, 2023	SELL	$22.26 - $30.85 $116,486 - $161,438	-5,233 Reduced 36.86%	8,965 $208,000
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $201,057 - $284,260	10,073 Added 244.19%	14,198 $359,000
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $9,312 - $15,861	510 Added 14.11%	4,125 $79,000
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $183,893 - $257,334	-9,638 Reduced 72.72%	3,615 $92,000
Q1 2022 May 16, 2022	SELL	$21.19 - $40.01 $15,362 - $29,007	-725 Reduced 5.19%	13,253 $341,000
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $425,156 - $741,723	13,728 Added 5491.2%	13,978 $585,000
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $9,687 - $12,750	250 New	250 $12,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Vir Biotechnology, Inc. Transaction History